Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135065) titled 'Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Modulates Inflammatory Response in Patients with Sepsis: A Single-Center, Randomized Controlled Clinical Trial' on Oct. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
Condition:
sepsis
Intervention:
Treatment group:Place the auricular electrodes of the stimulator in the bilateral cavum conchae. The stimulation intensity ranges from 0.5 to 1.5 mA, start at 1.5 mA and gradually decrease the intensity according to the patient's tolerance until a tolerable l...